Evidence map›Paper›PMID 40556349›Full record

ArticleScandinavian journal of immunology2025

Evaluating IL1RA-Autoantibodies Across SARS-CoV-2-Related Diseases.

Anish Behere, Pär Hallberg, Axel Cederholm, Marco Cavalli, Ahmet Yalcinkaya, COVID‐HGE, Paul Bastard, Anne Puel, Jean-Laurent Casanova, Mia Wadelius and 2 more

Abstract readLetter
In one paragraph

Article in Scandinavian journal of immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anish BehereScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.ORCID https://orcid.org/0000-0002-2424-3475
Pär HallbergDepartment of Medical Sciences, Clinical Pharmacogenomics, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Axel CederholmScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Marco CavalliDepartment of Medical Sciences, Clinical Pharmacogenomics, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.ORCID https://orcid.org/0000-0003-1143-1431
Ahmet YalcinkayaScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
COVID‐HGE
Paul BastardPediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital for Sick Children, (Assistance Publique-Hôpitaux de Paris) AP-HP, Paris Cité University, Paris, France.
Anne PuelLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.ORCID https://orcid.org/0000-0003-2603-0323
Jean-Laurent CasanovaLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.
Mia WadeliusDepartment of Medical Sciences, Clinical Pharmacogenomics, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Petter BrodinDepartment of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.
Nils LandegrenScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.

Funding

Göran Gustafssons Stiftelser 2141Knut och Alice Wallenbergs Stiftelse KAW 2021.0010Knut och Alice Wallenbergs Stiftelse VC-2020-0040Vetenskapsrådet 2021-03118Vetenskapsrådet 2021-05450
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adverse events following immunisationautoantibodiesCOVID‐19IL1RAMIS‐Cmyocarditis

Identifiers

PMID40556349
PMCPMC12188108

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.